← Back to front page
United States · Platforms & data · Stocktwits

SMMT Stock Plunges Overnight On FDA Rejection — CAPR Holders Feel The Jitters Ahead Of Their Own FDA Test

Published by Stocktwits · United States 11 h ago
SMMT Stock Plunges Overnight On FDA Rejection — CAPR Holders Feel The Jitters Ahead Of Their Own FDA Test
Stocktwits

Detailed summary

SMMT shares plunged 20% overnight late Sunday after the FDA rejected its Ivonescimab-plus-chemotherapy application for a lung cancer indication.

Read the full article on Stocktwits Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stocktwits.com)

Also worth reading